Aug 22, 2023 06:49 PM
PODCAST
China Stories: Brand-Name Drugs Feel the Squeeze in China’s Generic-Heavy Market
Aug.22.2023
Multinational pharmaceutical firms are changing strategies and selling business lines, as a government bulk-buying program favors cheaper, local products
00:00/00:00
Note: This is an audio narration of a Caixin Global article first published on June 2, 2023.
Contact reporter Zhang Yukun (yukunzhang@caixin.com)
Download our app to receive breaking news alerts and read the news on the go.
Share this article
Open WeChat and scan the QR code
MORE WAYS TO LISTEN
MOST POPULAR
- 1China Moves to Tighten Air-Quality Standards as Beijing Reports Best-Ever Skies
- 2China Threatens EU After Carbon Border Tax Takes Effect
- 3Cover Story: How Resource Nationalism Is Redrawing the Global Mineral Playbook
- 4Gansu Ex-Vice Governor Jailed 15 Years for Bribery, Insider Trading
- 5Trump Orders Chinese-Controlled Firm to Unwind Purchase of U.S. Chip Assets
SPONSORED
- 1Power To The People: Pintec Serves A Booming Consumer Class
- 2Largest hotel group in Europe accepts UnionPay
- 3UnionPay mobile QuickPass debuts in Hong Kong
- 4UnionPay International launches premium catering privilege U Dining Collection
- 5UnionPay International’s U Plan has covered over 1600 stores overseas

